Compared to the vehicle control, in rats treated with AG490, as a JAK2 phosphorylation inhibitor, in the sham group, JAK2 and STAT3 phosphorylation did not occur after ischemia; also, the infarct volume and apoptotic cells were significantly decreased, and neurological deficits were improved. The gene discussed is JAK2; the disease is ischemia.